Office of Biostatistics Cytel Software

Past New Requirement Updated

Agency
Solicitation expected
Estimated value
$25,000 to $250,000
Set-aside
No set-aside

Forecast facts

Anticipated award
NAICS code
519130 Internet Publishing and Broadcasting and Web Search Portals
Points of contact

Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.

About this forecast

The Food and Drug Administration's Office of Biostatistics is seeking Cytel Software to support review work involving power and sample size calculations, adaptive designs using EAST software, and exact statistical calculations through StatXact. The procurement encompasses biostatistical software solutions required for FDA regulatory review processes, with cost increases attributed to enhanced StatXact procedures integrated with SAS and SARGE functionality. The solicitation is expected to be released on May 1, 2026, with an estimated contract award date of September 1, 2026.

The estimated award value ranges from $25,000 to $250,000, reflecting the software licensing and associated costs for the FDA's biostatistical operations. This new requirement is classified under NAICS code 519130 (Internet Publishing and Broadcasting and Web Search Portals) and will be performed by the FDA. Interested parties should direct inquiries to the FDA's Acquisition Liaison at cderacquisitions@fda.hhs.gov or the general mailbox contact at tbd@fda.hhs.gov for additional information regarding this opportunity.

Forecast text

Office of Biostatistics Cytel Software Required for review work, specifically power and sample size calculations, adaptive designs (EAST), exact statistical calculations (StatXact). Increased cost driven in part by additional cost due to increase in costs of StatXact Procs with SARGE (SAS).

On GovTribe

Work this forecast

  • Track it in your pipeline
  • Find teaming partners
  • Similar forecasts
  • Ask GovTribe AI about this forecast